Dechra Pharmaceuticals PLC Director/PDMR Shareholding (6917G)
05 March 2018 - 9:58PM
UK Regulatory
TIDMDPH
RNS Number : 6917G
Dechra Pharmaceuticals PLC
05 March 2018
5 March 2018
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
LEI: 213800J4UVB5OWG8VX82
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Exercise of SAYE options:
Dechra Pharmaceuticals PLC announces that on 2 March 2018 Ian
Page (PDMR) exercised options, pursuant to Dechra Pharmaceuticals
PLC Save As Year Earn Scheme, over 1,465 ordinary shares of 1p each
(Ordinary Shares) at an exercise price of GBP6.14 per share.
Following this acquisition, Ian Page's beneficial interest in
the Company is 738,697 shares (0.722% of the current issued share
capital).
The Notification of Dealing Form set out below is provided in
accordance with the requirements of the EU Market Abuse
Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- ---------------------------------------------------------------
a) Name Ian Page
--- ------------------------------ -------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Director/PDMR
--- ------------------------------ -------------------------------
b) Initial notification/ Initial Notification
amendment
--- ------------------------------ -------------------------------
3. Details of the Issuer
--- ---------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ------------------------------ -------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--- ------------------------------ -------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument
Identification ISIN: GB0009633180
code
--- ------------------------------ -------------------------------
b) Nature of Exercise of 1,465 options
the transaction under the Company's Save As
You Earn Scheme
--- ------------------------------ -------------------------------
c) Price(s) and Price(s) Volume(s)
volumes(s)
GBP6.14 1,465
--- ------------------------------ -------------- ---------------
d) Aggregated
information
* Aggregate volume 1,465
GBP8,995.10
* Price
--- ------------------------------ -------------------------------
e) Date of the 2018.03.02
transaction
--- ------------------------------ -------------------------------
f) Place of the Outside a trading venue
transaction
--- ------------------------------ -------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFKPDPKBKDPNK
(END) Dow Jones Newswires
March 05, 2018 05:58 ET (10:58 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024